Clinical trial

Study of LY2409021 in Participants With Type 1 Diabetes

NCT01640834

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-07-01

PhasePHASE1

Study timeline

Study start (unknown)2012-07-01Date precision: month

Registry last updated2018-10-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

LY2409021DRUG

PlaceboDRUG

GlucagonDRUG · verified · RxNorm: glucagon

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01640834 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.